全文获取类型
收费全文 | 31350篇 |
免费 | 4017篇 |
国内免费 | 31篇 |
出版年
2016年 | 290篇 |
2015年 | 391篇 |
2014年 | 503篇 |
2013年 | 783篇 |
2012年 | 757篇 |
2011年 | 811篇 |
2010年 | 576篇 |
2009年 | 494篇 |
2008年 | 692篇 |
2007年 | 762篇 |
2006年 | 715篇 |
2005年 | 734篇 |
2004年 | 714篇 |
2003年 | 732篇 |
2002年 | 720篇 |
2001年 | 1925篇 |
2000年 | 1898篇 |
1999年 | 1501篇 |
1998年 | 511篇 |
1997年 | 493篇 |
1996年 | 506篇 |
1995年 | 450篇 |
1994年 | 440篇 |
1993年 | 439篇 |
1992年 | 1110篇 |
1991年 | 1125篇 |
1990年 | 1095篇 |
1989年 | 1058篇 |
1988年 | 993篇 |
1987年 | 933篇 |
1986年 | 794篇 |
1985年 | 784篇 |
1984年 | 612篇 |
1983年 | 532篇 |
1982年 | 398篇 |
1981年 | 366篇 |
1980年 | 344篇 |
1979年 | 583篇 |
1978年 | 469篇 |
1977年 | 431篇 |
1976年 | 352篇 |
1975年 | 472篇 |
1974年 | 486篇 |
1973年 | 435篇 |
1972年 | 404篇 |
1971年 | 327篇 |
1970年 | 278篇 |
1969年 | 251篇 |
1968年 | 246篇 |
1967年 | 217篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
93.
94.
M Magnani L Chiarantini E Vittoria U Mancini L Rossi A Fazi 《Biotechnology and applied biochemistry》1992,16(2):188-194
The use of adjuvants is usually required to induce strong immunological responses to protein antigens. However, in many cases these adjuvants cannot be extensively applied in human and veterinary vaccinations because of associated inflammatory reactions or granuloma formation. We show here that protein antigens (bovine serum albumin, hog liver uricase, and yeast hexokinase), coupled to autologous red blood cells by way of a biotin-avidin-biotin bridge, elicit an immunological response in mice similar to or higher than that obtained by the use of Freund's adjuvant. Quantities as low as 0.5 micrograms/mouse are high enough to generate these immunological responses. Furthermore, splenocytes of mice immunized by red blood cell-coupled antigens can be used to generate hybridomas secreting monoclonal antibodies. Thus, the delivery of antigens by autologous red blood cells is an effective way to avoid the use of adjuvants for producing anti-peptide antibodies and possibly to generate peptide vaccines. 相似文献
95.
U. M. X. Sangodkar T. L. Aldrich R. A. Haugland J. Johnson R. K. Rothmel P. J. Chapman A. M. Chakrabarty 《Engineering in Life Science》1989,9(4):301-316
Chlorinated aromatic hydrocarbons are widely used in industry and agriculture, and comprise the bulk of environmental pollutants. Although simple aromatic compounds are biodegradable by a variety of degradative pathways, their halogenated counterparts are more resistant to bacterial attack and often necessitate evolution of novel pathways. An understanding of such evolutionary processes is essential for developing genetically improved strains capable of mineralizing highly chlorinated compounds. This article provides an overview of the genetic aspects of dissimilation of chloroaromatic compounds and discusses the potential of gene manipulation to promote enhanced evolution of the degradative pathways. 相似文献
96.
97.
Cadmium ions introduced at concentration of 30 ppm to the cultivation medium of synchronously growing Chlorella vulgaris decreased concentration of chlorophylls a and b, carotenes alpha and beta and lutein at various stages of the cell cycle, while at concentration of 1 ppm synthesis of the photosynthetic pigments was stimulated. The pigment content in the cadmium treated cells was related to the morphometrically determined changes in the size and shape of the cells. 相似文献
98.
99.
Biocatalysis has ancient roots, yet it is developing into a key tool for synthesis in a wide range of applications. Important events in the history of enzyme technology from the 19th century onwards are highlighted. Considering the most relevant progress steps, the production of penicillanic acid and the impact of genetic engineering are traced in more detail. Applied biocatalysis has been defined as the application of a biocatalyst to achieve a desired conversion selectively, under controlled, mild conditions in a bioreactor. Biocatalysts are currently used to produce a wide range of products in the fields of food manufacture (such as bread, cheese, beer), fine chemicals (e.g., amino acids, vitamins), and pharmaceuticals (e.g., derivatives of antibiotics). They not only provide access to innovative products and processes, but also meet criteria of sustainability. In organic synthesis, recombinant technologies and biocatalysts have greatly widened the scope of application. Examples of current applications and processes are given. Recent developments and trends are presented as a survey, covering new methods for accessing biodiversity with new enzymes, directed evolution for improving enzymes, designed cells, and integrated downstream processing. 相似文献
100.
An expression construct for human tissue-type plasminogen activator (t-pA) cDNA [containing a simian virus 40 (SV40) origin of replication] was introduced into CV1, COS-7 and COSts2 cells; in the latter cell line the amount of functionally active large T antigen of SV40 is regulated by the temperature. In a transient system, the expression in COSts2 cells at the permissive temperature for large T antigen was improved sixfold compared to COS-7 cells. By cotransfection with a plasmid conferring resistance to G418 into COSts2 cells, a cell line (COSts2Glob t-pA) could be isolated with barely detectable expression of t-pA at the semi-permissive and non-permissive temperature and inducible secretion of t-pA at the permissive temperature. The kinetics of induction, inducibility after continued propagation at the semi-permissive temperature and the influence of the temperature during previous propagation on inducibility were investigated. The biological activity of the secreted material was demonstrated by a functional assay. Inducibility of t-pA by temperature was accompanied by a dramatic increase of the copy number of episomal plasmids (up to 2000 copies per cell). 相似文献